Bone Regeneration; Bone Substitutes; Growth Factors; Platelet-Rich Fibrin; Preclinical study Similarly, an injectable platelet-rich fibrin (i-PRF) was also developed by decreasing the G-force (700 rpm ...

A 34-year-old woman (gravida 3, para 2) at 16 weeks’ gestation was found to have platelets unable to be quantified because of clumping on routine prenatal blood work, with a visual estimate of 40 ...

1 Hematology Unit, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia 2 College of Medicine, Alfaisal University, ...

Background Chronic kidney disease is common in patients with coronary artery disease (CAD) and can significantly affect drug excretion and efficacy. This study focuses on the effects of modification ...

1 College of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea 2 College of Veterinary Medicine, Jeonbuk National University, Iksan, Republic of Korea Background: ...

Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...

The primary results of the REVERSE-IT trial showed that bentracimab restored platelet function, demonstrating the ability to reverse the effects of ticagrelor in patients on ticagrelor who underwent ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...